HMGB2 and esophageal squamous cell carcinoma: This study not only elucidates the molecular mechanism of NK cell dysfunction, but also provides a theoretical basis for the development of CRISPR-engineered NK cells.HMGB2 is expected to become a novel target for ESCC immunotherapy and provide an innovative direction for clinical NK cell therapy strategies.